Citation: | CHEN Wu, SONG Biao, WANG Bin, LI Yuan, SONG Qilong, WANG Zhaohua, MIN Xuhong. CT imaging diagnosis of primary pulmonary mucinous adenocarcinoma[J]. Chinese Journal of General Practice, 2023, 21(7): 1197-1201. doi: 10.16766/j.cnki.issn.1674-4152.003083 |
[1] |
HAN Y P, LUO Y J. Primary lung invasive adenocarcinoma misdiagnosed as infectious pneumonia in 18F-FDG PET/CT: a case report[J]. Radiol Case Rep, 2021, 17(3): 808-811.
|
[2] |
李媛, 谢惠康, 武春燕. WHO胸部肿瘤分类(第5版)中肺肿瘤部分解读[J]. 中国癌症杂志, 2021, 31(7): 574-580. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202109001.htm
LI Y, XIE H K, WU C Y. Interpretation of lung tumors in WHO classification of thoracic tumors (5th edition)[J]. Chinese Journal of Oncology, 2021, 31(7): 574-580. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202109001.htm
|
[3] |
邵元伟, 滕敏敏, 王晓蕾, 等. 原发性肺浸润性黏液腺癌的临床病理特征与CT表现[J]. 中国临床医学影像杂志, 2020, 31(10): 719-722, 726. https://www.cnki.com.cn/Article/CJFDTOTAL-LYYX202010011.htm
SHAO Y W, TENG M M, WANG X L, et al. Clinicopathological features and CT findings of primary pulmonary invasive mucinous adenocarcinoma[J]. Chinese Journal of Clinical Medical Imaging, 2020, 31(10): 719-722, 726. https://www.cnki.com.cn/Article/CJFDTOTAL-LYYX202010011.htm
|
[4] |
包杰, 金银华, 华奇峰, 等. 结合病理对原发性肺粘液腺癌的MSCT表现分析[J]. 医学影像学杂志, 2020, 30(5): 871-874. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXZ202005042.htm
BAO J, JIN Y H, HUA Q F, et al. Analysis of MSCT manifestations of primary pulmonary mucinous adenocarcinoma combined with pathology[J]. Journal of Medical Imaging, 2020, 30(5): 871-874. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXZ202005042.htm
|
[5] |
孙伟, 于跃, 李俊, 等. 肺浸润性黏液腺癌的病理影像学特征及治疗方法应用研究进展[J]. 山东医药, 2022, 62(15): 103-107. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202215024.htm
SUN W, YU Y, LI J, et al. Research progress on pathologic imaging features and therapeutic methods of pulmonary invasive mucinous adenocarcinoma[J]. Shandong Medical Journal, 2022, 62(15): 103-107. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202215024.htm
|
[6] |
SHENG A Z, ZHOU P F, YE Y Z, et al. Diagnostic efficacy of CT radiomic features in pulmonary invasive mucinous adenocarcinoma[J]. Scanning, 2022, 2022: 5314225. DOI: 10.1155/2022/5314225.
|
[7] |
杨昭, 王小雷, 李淑华, 等. CT影像组学列线图评估肺腺癌脏层胸膜侵犯[J]. 中国医学影像技术, 2022, 38(7): 1017-1022. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX202207012.htm
YANG Z, WANG X L, LI S H, et al. Identification of pleural invasion of the visceral layer of lung adenocarcinoma by CT radiomics[J]. Chinese Journal of Medical Imaging Technology, 2022, 38(7): 1017-1022. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX202207012.htm
|
[8] |
MIYATA N, ENDO M, NAKAJIMA T, et al. High-resolution computed tomography findings of early mucinous adenocarcinomas and their pathologic characteristics in 22 surgically resected cases[J]. Eur J Radiol, 2015, 84(5): 993-997.
|
[9] |
张俊杰, 郝李刚, 许茜, 等. 基于临床及CT特征构建预测肺浸润性黏液腺癌的机器学习模型[J]. 中华全科医学, 2023, 21(1): 6-9, 49. doi: 10.16766/j.cnki.issn.1674-4152.002799
ZHANG J J, HAO L G, XU Q, et al. Construction of a machine learning model for predicting lung invasive mucinous adenocarcinoma based on clinical and CT features[J]. Chinese Journal of General Practice, 2023, 21(1): 6-9, 49. doi: 10.16766/j.cnki.issn.1674-4152.002799
|
[10] |
范真真, 高鹏. 肺炎型浸润性黏液型腺癌的CT和病理学特征分析[J]. 实用放射学杂志, 2022, 38(7): 1096-1099.
FAN Z Z, GAO P. CT and pathological features of invasive mucinous adenocarcinoma pneumoniae[J]. Journal of Practical Radiology, 2022, 38(7): 1096-1099.
|
[11] |
ZHOU C, ZHAO J K, SHAO J C, et al. Prognostic relevance of TTF-1 expression in stage I adenocarcinoma[J]. Oncotarget, 2017, 8(64): 107462-107468. DOI: 10.18632/oncotarget.22489.
|
[12] |
刘标, 周晓军. 非小细胞肺癌免疫组化标志物专家共识(2014)[J]. 临床与实验病理学杂志, 2015, 31(5): 481-487. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL201505001.htm
LIU B, ZHOU X J. Expert consensus on immunohistochemical markers for non-small cell lung cancer (2014)[J]. Journal of Clinical and Experimental Pathology, 2015, 31(5): 481-487. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL201505001.htm
|
[13] |
王彩霞, 王晓, 吕淑慧, 等. TTF-1、SP-A在肺腺癌诊断及鉴别诊断中的价值[J]. 临床与实验病理学杂志, 2008, 24(3): 280-283. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL200803010.htm
WANG C X, WANG X, LYU S H, et al. Value of TTF-1 and SP-A in the diagnosis and differential diagnosis of lung adenocarcinoma[J]. Journal of Clinical and Experimental Pathology, 2008, 24(3): 280-283. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL200803010.htm
|
[14] |
韩高华, 周晓军, 孟奎, 等. TTF-1在肺腺癌中的表达及其诊断意义[J]. 临床与实验病理学杂志, 2002, 18(6): 595-597. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL200206004.htm
HAN G H, ZHOU X J, MENG K, et al. Expression and diagnostic significance of TTF-1 in lung adenocarcinoma[J]. Journal of Clinical and Experimental Pathology, 2002, 18(6): 595-597. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL200206004.htm
|
[15] |
XU X L, SHEN W M, WANG D, et al. Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma[J]. Transl Lung Cancer Res, 2022, 11(3): 420-431.
|
[16] |
NIE K, NIE W, ZHANG Y X, et al. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings[J]. Cancer Imaging, 2019, 19(1): 47.
|
[17] |
留永健, 李霁, 王世波, 等. 晚期肺炎型肺癌: 一项中国单中心临床-放射-病理特征回顾性研究及预后分析[J]. 中国肺癌杂志, 2019, 22(6): 329-335. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ201906001.htm
LIU Y J, LI J, WANG S B, et al. Advanced pneumonic lung cancer: a retrospective study and prognostic analysis of single-center clinical-radiopathological features in China[J]. Chinese Journal of Lung Cancer, 2019, 22(6): 329-335. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ201906001.htm
|
[18] |
NAGASAKA M, POTUGARI B, NGUYEN A, et al. KRAS inhibitors- yes but what next? Direct targeting of KRAS- vaccines, adoptive T cell therapy and beyond[J]. Cancer Treat Rev, 2021, 101: 102309. DOI: 10.1016/j.ctrv.2021.102309.
|
[19] |
WANG T T, YANG Y, LIU X Y, et al. Primary invasive mucinous adenocarcinoma of the lung: prognostic value of CT Imaging features combined with clinical factors[J]. Korean J Radiol, 2021, 22(4): 652-662.
|